Table 5.
Clinical presentation |
cagA statusa |
vacA genotypeb |
|||||
---|---|---|---|---|---|---|---|
No. (%) of patients |
P value | No. (%) of patients with genotype |
P valuec | ||||
Positive (n = 222) | Negative (n = 38) | s1m1 (n = 107) | s1m2 (n = 37) | s2m2 (n = 98) | |||
Endoscopic evaluation | |||||||
Duodenitis | 40 (18) | 6 (16) | 0.74 | 22 (21) | 9 (24) | 15 (15) | 0.42 |
Esophagitis | 46 (21) | 17 (45) | 0.003 | 15 (14) | 11 (30) | 35 (36) | 0.001d |
Moderate or severe gastritis | 96 (43) | 19 (50) | 0.44 | 48 (45) | 19 (51) | 44 (45) | 0.77 |
All ulcers | 20 (9) | 3 (8) | 0.82 | 12 (11) | 3 (8) | 7 (7) | 0.58 |
Gastric ulcer | 16 (7) | 2 (5) | 0.65 | 12 (11) | 1 (3) | 4 (4) | 0.07 |
Medical chart review | |||||||
History of gastritis | 93 (42) | 13 (34) | 0.37 | 46 (43) | 11 (30) | 43 (44) | 0.28 |
History of PUD | 32 (14) | 4 (11) | 0.51 | 21 (20) | 4 (11) | 9 (9) | 0.08 |
Ulcer at enrollment or history of PUD | 46 (21) | 6 (16) | 0.47 | 29 (27) | 4 (11) | 12 (12) | 0.01e |
Persons with both cagA-positive and cagA-negative H. pylori colonies were considered to be infected with a cagA-positive strain.
vacA genotype s2m1 was left out due to the small sample size (n = 1).
The P value examines differences in clinical outcomes among the 3 vacA genotypes. Boldface type indicates significance.
P value for s1m1 compared to the other 2 genotypes, 0.0003.
P value for s1m1 compared to the other 2 genotypes, 0.003.